Dendron GmbH

Neurovascular devices for treating stroke and aneurysms are interesting to lots of folks these days, but hurdles of all kinds—regulatory, clinical and financial--and uncertain market potential keep en

UK investigators' recent decision to call an early halt to enrollment in a major study comparing neurosurgical clipping to endovascular coil treatment of ruptured cerebral aneurysms may signal a signi

While other device start-ups are turning away from international markets, ev3 is betting on them. By David Cassak In the early 1990s, the creation of the European Union, with its talk of harmonization